相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of Dual Orexin Receptor Antagonists (DORAs) for the Treatment of Insomnia
Paul J. Coleman et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Orexin Receptors: Pharmacology and Therapeutic Opportunities
Thomas E. Scammell et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
The orexin OX1 receptor exists predominantly as a homodimer in the basal state: potential regulation of receptor organization by both agonist and antagonist ligands
Tian-Rui Xu et al.
BIOCHEMICAL JOURNAL (2011)
Ligand-induced internalization of the orexin OX1 and cannabinoid CB1 receptors assessed via N-terminal SNAP and CLIP-tagging
Richard J. Ward et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Aberrant Expression of OX1 Receptors for Orexins in Colon Cancers and Liver Metastases: an Openable Gate to Apoptosis
Thierry Voisin et al.
CANCER RESEARCH (2011)
A New Perspective of Cannabinoid 1 Receptor Antagonists: Approaches Toward Peripheral CB1R Blockers without Crossing the Blood-Brain Barrier
Yen-Ku Wu et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Trans-activation between 7TM domains: implication in heterodimeric GABAB receptor activation
Carine Monnier et al.
EMBO JOURNAL (2011)
AT1R-CB1R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II
Raphael Rozenfeld et al.
EMBO JOURNAL (2011)
The oligomeric state sets GABAB receptor signalling efficacy
Laetitia Comps-Agrar et al.
EMBO JOURNAL (2011)
An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity
F. D. Christopoulou et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2011)
On the Existence of a Possible A2A-D2-β-Arrestin2 Complex: A2A Agonist Modulation of D2 Agonist-Induced β-Arrestin2 Recruitment
Dasiel O. Borroto-Escuela et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Heteromerization of the μ- and δ-Opioid Receptors Produces Ligand-Biased Antagonism and Alters μ-Receptor Trafficking
Laura Milan-Lobo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
G Protein-Coupled Receptor Heteromerization: A Role in Allosteric Modulation of Ligand Binding
Ivone Gomes et al.
MOLECULAR PHARMACOLOGY (2011)
Facilitation of μ-Opioid Receptor Activity by Preventing δ-Opioid Receptor-Mediated Codegradation
Shao-Qiu He et al.
NEURON (2011)
Physical and functional interaction between CB1 cannabinoid receptors and β2-adrenoceptors
Brian D. Hudson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
The role of dimerisation in the cellular trafficking of G-protein-coupled receptors
Graeme Milligan
CURRENT OPINION IN PHARMACOLOGY (2010)
Opioid-receptor-heteromer-specific trafficking and pharmacology
Richard M. van Rijn et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Oligomeric Size of the M2 Muscarinic Receptor in Live Cells as Determined by Quantitative Fluorescence Resonance Energy Transfer
Luca F. Pisterzi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Ligand Regulation of the Quaternary Organization of Cell Surface M3 Muscarinic Acetylcholine Receptors Analyzed by Fluorescence Resonance Energy Transfer (FRET) Imaging and Homogeneous Time-resolved FRET
Elisa Alvarez-Curto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
Joseph Tam et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Ligand-Induced Regulation and Localization of Cannabinoid CB1 and Dopamine D2L Receptor Heterodimers
Julie A. Przybyla et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Ligand- and Heterodimer-Directed Signaling of the CB1 Cannabinoid Receptor
Brian D. Hudson et al.
MOLECULAR PHARMACOLOGY (2010)
Increasingly accurate dynamic molecular models of G-protein coupled receptor oligomers: Panacea or Pandora's box for novel drug discovery?
Marta Filizola
LIFE SCIENCES (2010)
Time-resolved FRET between GPCR ligands reveals oligomers in native tissues
Laura Albizu et al.
NATURE CHEMICAL BIOLOGY (2010)
Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects
Lin Pei et al.
NATURE MEDICINE (2010)
A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain
Xiao Hong Yu et al.
PAIN (2010)
Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes
Nicola J. Smith et al.
PHARMACOLOGICAL REVIEWS (2010)
Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules
Jonathan A. Hern et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Receptor heteromerization and drug discovery
Raphael Rozenfeld et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
The asymmetric/symmetric activation of GPCR dimers as a possible mechanistic rationale for multiple signalling pathways
Xavier Rovira et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Class A GPCR heterodimers: evidence from binding studies
Nigel J. M. Birdsall
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Modelling the interdependence between the stoichiometry of receptor oligomerization and ligand binding for a coexisting dimer/tetramer receptor system
X. Rovira et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function
Graeme Milligan
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Ligand-regulated oligomerization of β2-adrenoceptors in a model lipid bilayer
Juan Jose Fung et al.
EMBO JOURNAL (2009)
The Action and Mode of Binding of Thiazolidinedione Ligands at Free Fatty Acid Receptor 1
Nicola J. Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Adenosine A2A Receptor-Antagonist/Dopamine D2 Receptor-Agonist Bivalent Ligands as Pharmacological Tools to Detect A2A-D2 Receptor Heteromers
Aroa Soriano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
G-protein-coupled receptor oligomers: two or more for what? Lessons from mGlu and GABAB receptors
J. -P. Pin et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
Growth Hormone Secretagogues and Growth Hormone Releasing Peptides Act As Orthosteric Super-Agonists but Not Allosteric Regulators for Activation of the G Protein Gαo1 by the Ghrelin Receptor
Kirstie A. Bennett et al.
MOLECULAR PHARMACOLOGY (2009)
Determination of supramolecular structure and spatial distribution of protein complexes in living cells
Valerica Raicu et al.
NATURE PHOTONICS (2009)
Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and desensitization of the μ-opioid receptor
H. Schroeder et al.
NEUROPHARMACOLOGY (2009)
GPCR homomers and heteromers: A better choice as targets for drug development than GPCR monomers?
Vicent Casado et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth
Ahmed Hasbi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Hetero-oligomerization of the P2Y(11) receptor with the P2Y(1) receptor controls the internalization and ligand selectivity of the P2Y(11) receptor
Denise Ecke et al.
BIOCHEMICAL JOURNAL (2008)
A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization
G. Milligan
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Physiological relevance of GPCR oligomerization and its impact on drug discovery
Rosemarie Panetta et al.
DRUG DISCOVERY TODAY (2008)
Dopamine D2 receptors form higher order oligomers at physiological expression levels
Wen Guo et al.
EMBO JOURNAL (2008)
Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed mu opioid receptors
Meritxell Canals et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
μ-Opioid Receptor Forms a Functional Heterodimer With Cannabinoid CB1 Receptor: Electrophysiological and FRET Assay Analysis
Minoru Hojo et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Identification of a serotonin/glutamate receptor complex implicated in psychosis
Javier Gonzalez-Maeso et al.
NATURE (2008)
Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization
Damien Maurel et al.
NATURE METHODS (2008)
Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers.: A combined neurochemical and behavioral analysis
Daniel Marcellino et al.
NEUROPHARMACOLOGY (2008)
G protein-coupled receptor dimers: Functional consequences, disease states and drug targets
Matthew B. Dalrymple et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Allosteric modulation of heterodimeric G-protein-coupled receptors
Graeme Milligan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
The α1b-adrenoceptor exists as a higher-order oligomer:: Effective oligomerization is required for receptor maturation, surface delivery, and function
Juan F. Lopez-Gimenez et al.
MOLECULAR PHARMACOLOGY (2007)
Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1
Lene Martini et al.
FASEB JOURNAL (2007)
D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum
Asim J. Rashid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Allosteric properties of G protein-coupled receptor oligomers
Jean-Yves Springael et al.
PHARMACOLOGY & THERAPEUTICS (2007)
μ opioid and CB1 cannabinoid receptor interactions:: reciprocal inhibition of receptor signaling and neuritogenesis
Carl Rios et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function
James Ellis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
G-protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery
Graeme Milligan
DRUG DISCOVERY TODAY (2006)
Characterisation of the binding of [H-3]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor
CJ Langmead et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
C5a receptor oligomerization - I. Disulfide trapping reveals oligomers and potential contact surfaces in a G protein-coupled receptor
JM Klco et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Hypersensitization of the orexin 1 receptor by the CB1 receptor -: Evidence for cross-talk blocked by the specific CB1 antagonist, SR141716
S Hilairet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
分享论文
